Open AccessP361: EARLY MEASURABLE RESIDUAL DISEASE ANALYSIS IS ONLY PREDICTIVE OF SURVIVAL OUTCOMES AFTER TWO CYCLES OF TREATMENT IN ADULTS WITH B‐LYMPHOBLASTIC LEUKEMIA RECEIVING HYPER‐CVAD INDUCTION.
Author(s) -
Nedumannil R.,
Ritchie D.,
Bajel A.,
Ng A. P.,
Harrison S. J.,
Westerman D.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844332.40790.06
Subject(s) - medicine , cytarabine , methotrexate , chemotherapy , induction chemotherapy , minimal residual disease , vincristine , cyclophosphamide , oncology , regimen , surgery , leukemia